Target intelligence / Profile preview

Immunoglobulin lambda variable 4-3 (IGLV4-3)

Target
IGLV4-3
Molecular classification
Other (immunoglobulin variable region), Immunoglobulin variable domain
01

Overview

Immunoglobulin lambda variable 4-3 is a **variable domain segment** of the immunoglobulin (antibody) light chain, specifically the lambda light chain family, subgroup 4-3. This segment is part of the V (variable) region, which is essential for **antigen recognition** as a component of the immunoglobulin molecule. During B-cell development, variable domains like IGLV4-3 undergo recombination and contribute to the generation of immunoglobulin diversity by pairing with a joining (J) segment and a constant (C) segment, resulting in a mature light chain that combines with a heavy chain. The binding site for antigens is constructed from the variable regions of both the immunoglobulin heavy and light chains, giving rise to antibody specificity[1][3]. IGLV4-3 participates in the recognition phase of the humoral immune response; membrane-bound immunoglobulins serve as B-cell receptors, while secreted forms mediate effector functions through antigen binding and elimination. The gene is located on chromosome 22q11.2 and is one of many genes that encode variable regions for the lambda light chain locus[5]. IGLV4-3 is not a therapeutic target, receptor, or enzyme in the conventional sense, but it is essential to the molecular structure and function of antibodies in adaptive immunity[1][3].

Other names
IGLV4-3IGLV43V5-1
02

Biological functions

Immune responseAntigen recognition
03

Disease associations

Other (potential association with immune dysregulation; specific disease roles not established)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 4-3 (IGLV4-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 4-3 (IGLV4-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call